RaiseCare Biotech has closed over RMB 100 million ($13.6 million) Series B financing led by CITIC Health Fund, followed by CCI Fund, Chongqing Yinuo Private Equity, and Qingdao Jufeng Venture Capital.

Founded in 2016, Qingdao, Shandong-based RaiseCare Biotech is a high-tech company engaged in the research and development, production, and sales of in vitro diagnostic products.

The company focuses on flow diagnostics, from raw materials to product development and clinical application research, and provides innovative total solutions including flow cytometers and related reagents to more than 1,000 hospitals in China.

es_ESEspañol